All News about Nls Pharmaceutics Ltd
Benzinga's Top Ratings Upgrades, Downgrades For September 6, 2022
September 06, 2022
Via Benzinga
Via Benzinga
From NLS Pharmaceutics AG
Via AccessWire
From NLS Pharmaceutics AG
Via AccessWire
From NLS Pharmaceutics AG
Via AccessWire
From NLS Pharmaceutics AG
Via AccessWire
From NLS Pharmaceutics AG
Via AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
NLS Pharmaceutics Ltd. Announces Closing of US$4.4 Million Registered Direct Offering
April 26, 2022
From NLS Pharmaceutics AG
Via AccessWire
Topics
Regulatory Compliance
From NLS Pharmaceutics AG
Via AccessWire
From NLS Pharmaceutics AG
Via AccessWire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|